STOCK TITAN
  1. Home
  2. Sec-filings
  3. ATXS
  4. [425] – Astria Therapeutics, Inc. (ATXS) (CIK 0001454789)

[425] – Astria Therapeutics, Inc. (ATXS) (CIK 0001454789)

Filing Impact
(Moderate)
Filing Sentiment
(Neutral)
Form Type
425
Rhea-AI Filing Summary
Analyzing...
Positive
  • None.
Negative
  • None.

Insights

Analyzing...

Filing content is currently unavailable.

Source: View Original Filing on SEC EDGAR

Stock ATXS logo
Astria Therapeutics Inc

NASDAQ:ATXS

ATXS Rankings

#3420 Ranked by Market Cap
N/A Ranked by Dividends

ATXS Latest News

Oct 14, 2025
BioCryst to Acquire Astria Therapeutics, Strengthening Presence in HAE, Transforming Growth Profile
Oct 9, 2025
Astria Therapeutics to Present at Upcoming CSACI 80th Anniversary Scientific Meeting
Oct 8, 2025
Astria Therapeutics Initiates the Phase 3 ORBIT-EXPANSE Long-Term Trial of Navenibart in People with Hereditary Angioedema
Oct 3, 2025
Astria Therapeutics to Present at Upcoming 2025 HAEi Regional Conference EMEA
Oct 2, 2025
Astria Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

ATXS Latest SEC Filings

Oct 14, 2025
[425] – Astria Therapeutics, Inc. (ATXS) (CIK 0001454789)
Oct 14, 2025
[425] – Astria Therapeutics, Inc. (ATXS) (CIK 0001454789)
Oct 14, 2025
[425] – Astria Therapeutics, Inc. (ATXS) (CIK 0001454789)
Oct 14, 2025
[425] – Astria Therapeutics, Inc. (ATXS) (CIK 0001454789)
Oct 14, 2025
[8-K] – Astria Therapeutics, Inc. (ATXS) (CIK 0001454789)

ATXS Stock Data

478.00M
49.67M
0.49%
102.52%
4.94%
Biotechnology
Pharmaceutical Preparations
Link
United States
BOSTON